8.4 Structured Reporting & Perinatal Management Protocols

Structured Fetal Echocardiography Reporting

The fetal echocardiogram report is the definitive document communicating the sonographic findings, the anatomical diagnosis, and the functional status of the fetal heart to the referring physician and the multidisciplinary care team. To ensure quality and consistency, reporting should strictly adhere to guidelines established by professional societies such as the American Institute of Ultrasound in Medicine (AIUM), the American Society of Echocardiography (ASE), and the American Heart Association (AHA).

A high-quality, structured report minimizes ambiguity and ensures all necessary components of the exam were completed or documented as technically limited. The essential components of a standard report include:

1. Patient Demographics and Exam Indications: Clearly state maternal age, gestational age (by LMP or early ultrasound), and the specific indication for the fetal echocardiogram (e.g., suspected anomaly on screening, maternal diabetes, family history).
2. Technical Limitations: Document any factors that compromised image quality, such as maternal body habitus, oligohydramnios, unfavorable fetal position, or early/late gestational age. Acknowledging limitations is crucial for medicolegal reasons and for planning follow-up.
3. Cardiac Biometry: Include standard measurements, typically expressed as absolute values and Z-scores based on gestational age or estimated fetal weight. Key measurements include:
   • Cardiothoracic ratio.
   • Atrial and ventricular dimensions.
   • Aortic and pulmonary valve annulus diameters.
   • Dimensions of the great arteries (ascending aorta, main pulmonary artery).
4. Segmental Anatomical Analysis: This is the core of the report. It should systematically describe the anatomy using the segmental approach:
   • Situs: Visceral and atrial arrangement (solitus, inversus, right/left isomerism).
   • Atrioventricular (AV) Connections: Concordant, discordant, ambiguous, or absent. Describe the morphology and competence of the mitral and tricuspid valves.
   • Ventriculoarterial (VA) Connections: Concordant, discordant, double outlet, or single trunk. Describe the aortic and pulmonary valves and the caliber and relationship of the great vessels.
   • Septation: Integrity of the atrial and ventricular septa.
   • Venous Returns: Systemic (SVC, IVC) and pulmonary venous connections.
   • Aortic Arch: Sidedness (left/right) and continuity (absence of coarctation or interruption).
5. Rhythm and Rate: Document the baseline fetal heart rate (e.g., 140 bpm) and state that the rhythm is regular, or describe any arrhythmias (PACs, SVT, AV block) using M-mode/Doppler evidence.
6. Functional Assessment: Detail the presence or absence of structural markers of heart failure (hydrops, cardiomegaly). Describe ventricular systolic function (qualitative assessment, ejection fraction, shortening fraction) and AV valve competence (presence/severity of regurgitation).
7. Summary/Conclusion: A concise synthesis of the findings. If an anomaly is present, state the specific diagnosis (e.g., "Findings consistent with Tetralogy of Fallot").
8. Recommendations: Outline the plan, which may include follow-up imaging intervals, referrals (Maternal-Fetal Medicine, Pediatric Cardiology, Genetics), and initial delivery planning.

Perinatal Management Protocols and Delivery Planning

The antenatal diagnosis of significant congenital heart disease (CHD) profoundly alters obstetric and neonatal management. The primary goal is to transition the neonate safely from the parallel fetal circulation to the postnatal series circulation. This requires a highly coordinated, multidisciplinary approach involving Pediatric Cardiology, Maternal-Fetal Medicine, Neonatology, Cardiothoracic Surgery, and specialized nursing teams.

Level of Care Recommendations: A critical outcome of the fetal diagnosis is determining the appropriate location for delivery. The AHA provides guidelines for stratifying delivery risk:

• Level I-II: Fetuses with minor anomalies (small VSDs, mild valve stenosis) without anticipated neonatal compromise can often deliver at local hospitals with standard nursery care, followed by outpatient cardiology evaluation.
• Level III: Fetuses with significant CHD requiring prompt neonatal evaluation, monitoring, and potentially medical stabilization (e.g., uncomplicated Tetralogy of Fallot, Coarctation of the aorta) should deliver at a center with a Level III Neonatal Intensive Care Unit (NICU) and immediate access to a pediatric cardiologist.
• Level IV (Highest Care): Fetuses with critical, ductal-dependent lesions or complex CHD requiring immediate postnatal intervention (e.g., Hypoplastic Left Heart Syndrome, Transposition of the Great Arteries, Total Anomalous Pulmonary Venous Return with obstruction, severe fetal heart failure/hydrops) MUST deliver at, or be immediately adjacent to, a comprehensive pediatric cardiac surgery center equipped for urgent neonatal cardiac surgery, catheterization, and ECMO (Extracorporeal Membrane Oxygenation) support.

PGE1 Initiation Protocols for Ductal-Dependent Lesions: Certain cardiac defects rely entirely on the patency of the ductus arteriosus for postnatal survival. In utero, the ductus is kept patent by low oxygen tension and circulating maternal/fetal prostaglandins. After birth, oxygenation and the loss of placental prostaglandins trigger ductal closure, which can rapidly lead to profound cyanosis, acidosis, cardiogenic shock, and death in these neonates.

A standardized protocol for the immediate postnatal initiation of intravenous Prostaglandin E1 (PGE1, Alprostadil) is essential for:

• Ductal-Dependent Systemic Circulation: Conditions where the left heart cannot supply the body, and systemic blood flow relies on right-to-left flow through the ductus (e.g., HLHS, Critical Aortic Stenosis, Severe Coarctation of the Aorta, Interrupted Aortic Arch).
• Ductal-Dependent Pulmonary Circulation: Conditions with inadequate forward flow to the lungs, relying on left-to-right flow through the ductus (e.g., Pulmonary Atresia, severe Tetralogy of Fallot, Critical Pulmonary Stenosis).
• Parallel Circulations: Conditions requiring mixing of systemic and pulmonary blood (e.g., Transposition of the Great Arteries - TGA). While a balloon atrial septostomy is often needed for TGA, PGE1 is initiated to maintain ductal mixing while awaiting the procedure.

The delivery room team must have the PGE1 infusion prepared prior to delivery. Upon birth, the neonate is stabilized, secured with intravenous access, and the PGE1 infusion is commenced immediately, bypassing the wait for postnatal echocardiographic confirmation if the fetal diagnosis is secure.

Parental Counseling

Receiving a fetal diagnosis of a major cardiac defect is a traumatic experience for expectant parents. Effective, compassionate, and accurate counseling is a critical component of the management protocol. Counseling should ideally be performed by a pediatric cardiologist in conjunction with the maternal-fetal medicine team.

Key principles of parental counseling include:

• Clarity and Honesty: Explain the diagnosis using simple diagrams and avoiding overly complex medical jargon. Be honest about the severity and the uncertainties.
• Surgical Pathways: Clearly outline the expected postnatal course. Differentiate between lesions that allow for a biventricular repair (normal circulation pathway, e.g., VSD, TOF) and those requiring single-ventricle palliation (e.g., Norwood-Glenn-Fontan pathway for HLHS). The long-term implications and survival differences between these pathways must be discussed.
• Morbidities and Outcomes: Discuss not just survival, but potential long-term neurodevelopmental outcomes, the need for reinterventions, and the impact on the child's quality of life. Provide current, center-specific or national outcome data.
• Genetic Testing: Strongly recommend genetic counseling and testing (amniocentesis with chromosomal microarray or exome sequencing), as many complex CHDs are associated with genetic syndromes (e.g., 22q11.2 deletion in conotruncal defects) that affect overall prognosis and management.
• Decision Making: Support parents in their decision-making process, which may include continuation of pregnancy with planned surgical intervention, palliative care (compassionate care at birth) for exceedingly severe defects, or pregnancy termination within legal limits.

Providing parents with a structured plan for delivery and postnatal care significantly reduces anxiety and empowers them as crucial members of the care team.